Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer

The present study evaluated the efficacy and safety of pemetrexed, carboplatin and bevacizumab, followed by maintenance pemetrexed and bevacizumab, in chemotherapy-naïve patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC). The patients were administered pemetrexed (500 mg/m2)...

Full description

Bibliographic Details
Main Authors: YOKOI, TAKASHI, TORII, YOSHITARO, KATASHIBA, YUICHI, SUGIMOTO, HIROYUKI, TANIJIRI, TSUTOMU, OGATA, MAKOTO, INAGAKI, NORIKO, KIBATA, KAYOKO, HAYASHI, MINA, NIKI, MAIKO, SHIMIZU, TOSHIKI, MIYARA, TAKAYUKI, KURATA, TAKAYASU, NOMURA, SHOSAKU
Format: Online
Language:English
Published: D.A. Spandidos 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214444/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214444/

Similar Items